
In this episode of Neurofounders Conversations, Dominic Borkelmans speaks with Raphael Certain, CEO and co-founder of Clarity Technologies, about the science behind sensory stimulation and its potential applications in neurodegenerative disease.
Clarity's technology combines synchronized light and sound stimulation at 40 Hz with immersive virtual reality environments. The approach aims to engage gamma-band brain activity, which researchers are investigating for its potential role in Alzheimer's disease.
We discuss the scientific rationale behind 40 Hz stimulation, the development of Clarity's technology, the potential of virtual reality for delivering neuromodulation, and the clinical research needed to establish whether sensory stimulation can produce meaningful therapeutic benefits.